Vitrolife AB

Update in progress

VITR.ST (Stockholm)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Vitrolife AB (publ) develops and supplies assisted reproduction products for Europe, the Middle East, Africa, Asia-Pacific and the Americas. Its offering includes sperm processing and oocyte retrieval needles, micromanipulation pipettes, time-lapse systems and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. It also provides eWitness and Labware products such as dishes, pipettes, tubes, and VitroTemp. Founded 1989, Gothenburg, Sweden.

Company score

Sentiment: 0.27; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.02; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.32; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.12; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.20; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive